"antigen binding protein, recombinant transfected or transfected host cell, pharmaceutical composition, method of treating a human patient, use of an antigen binding protein, method for reducing aggregation of an immunoglobulin single variable domain, vk dab derived from a germline structure, and immunoglobulin single variable domain. "
ALAN PETER LEWIS,CLAIRE ASHMAN,JONATHAN HENRY ELLIS,MARTIN ANIBAL ORECCHIA,PAUL ANDREW HAMBLIN
申请号：
BRPI1016061
公开号：
BRPI1016061A2
申请日:
2010.05.26
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention relates to antigen binding proteins to human IL-13, including anti-IL-13 antibodies and anti-IL-3/anti-IL-4 mAbdAbs, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as asthma or IPF.
